Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

Shares of TransMedics (TMDX) are falling after Scorpion Capital revealed its short position on the company Friday. The ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

TransMedics（TMDX）是一家在器官移植技术领域占据领先地位的公司，自2022年初至2024年中，该公司销售额连续10个财季增长超过100%。然而，最新一财季的收入增长率仅为64%，并且公司对于即将到来的第四财季下调了35%的增长预期，这使 ...

周一，派杰桑德勒 (Piper Sandler)分析师Matt O'Brien维持对专注于器官移植技术的TransMedics Group (NASDAQ:TMDX)的"增持"评级和90.00美元的目标价。O'Brien的乐观态度基于该公司近期的表现指标，包括器官移植量和TransMedics医疗专机机队的活动。

Shares of Transmedics (NASDAQ: TMDX) fell 28.1% in December, according to data from S&P Global Market Intelligence. On Dec. 2 ...

2025年1月8日，医疗保健技术公司TransMedics Group（TMDX）成交额为2.47亿美元，在当日美股中排第307名，成交额较昨日减少18.07%，当日成交量为334.04万。 TransMedics Group（TMDX）于2025年1月8日跌7.78%，报72.55美元，该股过去5个交易日涨16.36%，整个1月涨16.36%，年初至今涨16.36%，过去52周跌15.33%。

Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

Discover how TransMedics is revolutionizing organ transplants with cutting-edge technology and logistics, offering a ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...